SCTB41 Combined With Chemotherapy in Advanced Squamous Non-Small Cell Lung Cancer

NCT07662395 · clinicaltrials.gov ↗

PHASE2,PHASE3

Phase

RECRUITING

Status

410

Enrollment

INDUSTRY

Sponsor class

Conditions

Double Blind

Interventions

DRUG: SCTB41
DRUG: Tislelizumab
DRUG: Paclitaxel
DRUG: Nab-paclitaxel
DRUG: Carboplatin
DRUG: Cisplatin
DRUG: Pemetrexed

Sponsor

Sinocelltech Ltd.